Dr Clare Slaney
Honorary Conjoint Senior Fellow
The Sir Peter MacCallum Department of Oncology
18 Scholarly works
7 Projects
HIGHLIGHTS
2025
Journal article
Optimised modular anti-FLAG CAR T cells for solid tumor therapy
DOI: 10.1002/cti2.700462024
Journal article
Choice of activation protocol impacts the yield and quality of CAR T cell product, particularly with older individuals
DOI: 10.1002/cti2.700162024
Journal article
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy
DOI: 10.1038/s41586-024-07242-12023
Journal article
YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cells
DOI: 10.1038/s41467-023-37161-02020
Research grants (ARC, NHMRC, MRFF)
Car T Cells and "A Good Beating" for Cancer Therapy
2020
Research grants (other domestic)
Car T Cells and a Good \201cbeating\201d for Breast Cancers
2018
Research Grant
Using Lessons From Toxic Shock Syndrome to Enhance Breast Cancer Immunotherapy
RECENT SCHOLARLY WORKS
2023
Journal article
TSTEM-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models
DOI: 10.1126/scitranslmed.abk19002021
Journal article
A histone deacetylase inhibitor, panobinostat, enhances chimeric antigen receptor T-cell antitumor effect against pancreatic cancer
DOI: 10.1158/1078-0432.CCR-21-11412021
Journal article
Enhancing co-stimulation of CAR T cells to improve treatment outcomes in solid cancers
DOI: 10.1093/immadv/ltab0162017
Journal article
Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy
DOI: 10.1172/JCI894552015
Journal article
CD73: A potential biomarker for anti-PD-1 therapy
DOI: 10.1080/2162402X.2015.10466752015
Journal article
Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer
DOI: 10.1158/2326-6066.CIR-15-0065
RECENT PROJECTS
2017
Research Grant
Targeting Breast Cancer Using Adoptive Cell Transfer Incorporating Vaccination
2016
Research Grant
Breast Cancer Therapy Using Dual-Specific T Cells